RICOVR Healthcare raises $1.5M to commercialize rapid point-of-care testing device for Cannabis & COVID-19

NEXT STORY
Pyxis Oncology Hosting Key Opinion Webinar on Antibody-Drug Conjugates
PREV STORY
Agenus Submits Balstilimab Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Seasonal Probiotics Company Jetson Adds Leading Pediatrician and OBGYN to Advisory “Gut Council”

author_avatar
NASDAQ Market News

Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress

author_avatar
NASDAQ Market News

Global Disposable Incontinence Products Market Is Expected to Reach USD 18.59 billion by 2027 : Fior Markets

author_avatar
NASDAQ Market News